These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 122912)

  • 21. Treatment of insulinoma in a springer spaniel with streptozotocin.
    Bell R; Mooney CT; Mansfield CS; Jones BR
    J Small Anim Pract; 2005 May; 46(5):247-50. PubMed ID: 15909449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
    Chernicoff D; Bukowski RM; Groppe CW; Hewlett JS
    Cancer Treat Rep; 1979 May; 63(5):795-6. PubMed ID: 222449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study.
    Stiff PJ; McKenzie RS; Potempa LD; Albain K; Koch D; Braud E; Bansal VK; Weidner MK; Lanzotti VJ; Chun HG
    J Clin Oncol; 1991 Aug; 9(8):1487-94. PubMed ID: 2072148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II clinical evaluation of doxifluridine.
    Hurteloup P; Armand JP; Cappelaere P; Metz R; Kerbrat P; Keiling R; Fumoleau P; Fargeot P; Schraub S; Bastit P
    Cancer Treat Rep; 1986 Jun; 70(6):731-7. PubMed ID: 2942245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.
    Panella TJ; Smith DC; Schold SC; Rogers MP; Winer EP; Fine RL; Crawford J; Herndon JE; Trump DL
    Cancer Res; 1992 May; 52(9):2456-9. PubMed ID: 1533174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Zollinger-Ellison syndrome and metastatic insulinoma; its response to streptozotocin].
    Agular-Parada E; Rivadeneyra-Hinojosa J; Guzman-Patraca C; Salas-Montero J; Escalante-Herrera A
    Arch Invest Med (Mex); 1977; 8(1):31-8. PubMed ID: 192163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and pathological effects of streptozotocin.
    Loftus L; Cuppage FE; Hoogstraten B
    J Lab Clin Med; 1974 Sep; 84(3):407-13. PubMed ID: 4368506
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination chemotherapy of hepatocellular carcinoma with doxorubicin and streptozotocin.
    Morstyn G; Ihde DC; Eddy JL; Bunn PA; Cohen MH; Minna JD
    Am J Clin Oncol; 1983 Oct; 6(5):547-51. PubMed ID: 6310986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I studies on chlorozotocin.
    Hoth D; Woolley P; Green D; Macdonald J; Schein P
    Clin Pharmacol Ther; 1978 Jun; 23(6):712-22. PubMed ID: 148344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989-1999).
    Moore AS; Nelson RW; Henry CJ; Rassnick KM; Kristal O; Ogilvie GK; Kintzer P
    J Am Vet Med Assoc; 2002 Sep; 221(6):811-8. PubMed ID: 12322919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical studies with tubercidin administered by direct intravenous injection.
    Bisel HF; Ansfield FJ; Mason JH; Wilson WL
    Cancer Res; 1970 Jan; 30(1):76-8. PubMed ID: 4917978
    [No Abstract]   [Full Text] [Related]  

  • 33. A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
    Goss G; Siu LL; Gauthier I; Chen EX; Oza AM; Goel R; Maroun J; Powers J; Walsh W; Maclean M; Drolet DW; Rusk J; Seymour LK;
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):703-10. PubMed ID: 16528532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zollinger-Ellison syndrome. Streptozotocin therapy for metastatic gastrinomas.
    Huard GS; Stephens RL; Friesen SR
    J Kans Med Soc; 1981 May; 82(5):216-21. PubMed ID: 6453914
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase I study of carboplatin (CBDCA) in children with cancer.
    Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
    Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I study of pyrazofurin.
    Salem PA; Bodey GP; Burgess MA; Murphy WK; Freireich EJ
    Cancer; 1977 Dec; 40(6):2806-9. PubMed ID: 589556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I study of streptozocin- and carmustine-sequenced administration in patients with advanced cancer.
    Micetich KC; Futscher B; Koch D; Fisher RI; Erickson LC
    J Natl Cancer Inst; 1992 Feb; 84(4):256-60. PubMed ID: 1531148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial: Streptozotocin for islet-cell carcinoma.
    Lancet; 1973 Nov; 2(7837):1063-4. PubMed ID: 4127316
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase I and pharmacokinetic study of irinotecan administered as a low-dose, continuous intravenous infusion over 14 days in patients with malignant solid tumors.
    Herben VM; Schellens JH; Swart M; Gruia G; Vernillet L; Beijnen JH; ten Bokkel Huinink WW
    J Clin Oncol; 1999 Jun; 17(6):1897-905. PubMed ID: 10561231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I trial of subcutaneously administered recombination tumor necrosis factor to patients with advanced malignancy.
    Zamkoff KW; Newman NB; Rudolph AR; Young J; Poiesz BJ
    J Biol Response Mod; 1989 Oct; 8(5):539-52. PubMed ID: 2795095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.